Cantai Therapeutics
Latest round
- Seed
Last raised
- Nov 2023
Total raised
- $0.7M
Investors
- 3
About Cantai Therapeutics
, also known as Cantai, operates as a biotechnology company that offers drugs for patients suffering from autoimmune diseases. In November 2023, Cantai Therapeutics, Inc., and Tellus BioVentures. Cantai develops drug candidates, mainly cytokine-targeting bispecific antibodies, for patients with inflammatory disorders. The firm leverages human antibody discovery technologies to offer therapies for patients suffering from autoimmune diseases.
Who invested in Cantai Therapeutics
3 investors across 1 round
See all investors in Cantai Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 6, 2023
Amount
$0.7M
Investors
Questions about Cantai Therapeutics
Who invested in Cantai Therapeutics?
Cantai Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cantai Therapeutics raised?
Cantai Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cantai Therapeutics last raise money?
Cantai Therapeutics's most recent round on record is a Seed, in Nov 2023.
What does Cantai Therapeutics do?
, also known as Cantai, operates as a biotechnology company that offers drugs for patients suffering from autoimmune diseases.
Where is Cantai Therapeutics headquartered?
Cantai Therapeutics is headquartered in Philadelphia, US.
Which VCs invest in companies like Cantai Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cantai Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Cantai Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.